Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Clinical trial NCT02965378 · COMPLETED

Trial details

NCT number: NCT02965378
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

FGFR1 Gene Amplification FGFR1 Gene Mutation FGFR2 Gene Amplification FGFR2 Gene Mutation FGFR3 Gene Amplification FGFR3 Gene Mutation Recurrent Squamous Cell Lung Carcinoma Stage IV Squamous Cell Lung Carcinoma AJCC v7

Start date: 2014-10-01
Primary completion: 2017-01-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.